Biocentis
PrivateLast Round
Grant
Nov 19, 2025
Total Funding Raised
$6.91M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Biocentis is a biotechnology company that develops next-generation genetic technologies and AI-driven solutions for sustainable insect control to protect public health, agriculture, and biodiversity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Environmental Monitoring
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biocentis Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Biocentis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 19, 2025 | ||||
| Grant | Nov 27, 2023 | ||||
| Grant | Oct 14, 2023 | ||||
| Pre Seed | Feb 1, 2023 |
Biocentis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Neurone | Grant, Pre Seed |
| Corbites | Grant |
| The Grantham Foundation for the Protection of the Environment | Grant |
| Jeremy and Hannelore Grantham Environmental Trust | Grant |
| Italian Ministry of University and Research | Grant |
| Novaterra | Grant |
| Algebris Investments | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 19, 2025
$19M raised in Seed round.
- Oct 14, 2023
$445K grant round completed.
Biocentis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biocentis's valuation, stock price, and market status.